A plasmid locus associated with Klebsiella clinical infections encodes a microbiome-dependent gut fitness factor.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
04 2021
Historique:
received: 27 01 2021
accepted: 07 04 2021
revised: 12 05 2021
pubmed: 1 5 2021
medline: 11 8 2021
entrez: 30 4 2021
Statut: epublish

Résumé

Klebsiella pneumoniae (Kp) is an important cause of healthcare-associated infections, which increases patient morbidity, mortality, and hospitalization costs. Gut colonization by Kp is consistently associated with subsequent Kp disease, and patients are predominantly infected with their colonizing strain. Our previous comparative genomics study, between disease-causing and asymptomatically colonizing Kp isolates, identified a plasmid-encoded tellurite (TeO3-2)-resistance (ter) operon as strongly associated with infection. However, TeO3-2 is extremely rare and toxic to humans. Thus, we used a multidisciplinary approach to determine the biological link between ter and Kp infection. First, we used a genomic and bioinformatic approach to extensively characterize Kp plasmids encoding the ter locus. These plasmids displayed substantial variation in plasmid incompatibility type and gene content. Moreover, the ter operon was genetically independent of other plasmid-encoded virulence and antibiotic resistance loci, both in our original patient cohort and in a large set (n = 88) of publicly available ter operon-encoding Kp plasmids, indicating that the ter operon is likely playing a direct, but yet undescribed role in Kp disease. Next, we employed multiple mouse models of infection and colonization to show that 1) the ter operon is dispensable during bacteremia, 2) the ter operon enhances fitness in the gut, 3) this phenotype is dependent on the colony of origin of mice, and 4) antibiotic disruption of the gut microbiota eliminates the requirement for ter. Furthermore, using 16S rRNA gene sequencing, we show that the ter operon enhances Kp fitness in the gut in the presence of specific indigenous microbiota, including those predicted to produce short chain fatty acids. Finally, administration of exogenous short-chain fatty acids in our mouse model of colonization was sufficient to reduce fitness of a ter mutant. These findings indicate that the ter operon, strongly associated with human infection, encodes factors that resist stress induced by the indigenous gut microbiota during colonization. This work represents a substantial advancement in our molecular understanding of Kp pathogenesis and gut colonization, directly relevant to Kp disease in healthcare settings.

Identifiants

pubmed: 33930099
doi: 10.1371/journal.ppat.1009537
pii: PPATHOGENS-D-21-00210
pmc: PMC8115787
doi:

Substances chimiques

Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009537

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI125307
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007528
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI124255
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Proc Natl Acad Sci U S A. 2016 Oct 4;113(40):E5934-E5943
pubmed: 27638207
mSphere. 2017 Mar 8;2(2):
pubmed: 28289728
Nucleic Acids Res. 2017 Jan 4;45(D1):D535-D542
pubmed: 27899627
Bioinformatics. 2018 Mar 15;34(6):1053-1055
pubmed: 29091997
Cell Host Microbe. 2018 Aug 8;24(2):296-307.e7
pubmed: 30057174
Appl Environ Microbiol. 2013 Sep;79(17):5112-20
pubmed: 23793624
Bioinformatics. 2006 Jul 1;22(13):1658-9
pubmed: 16731699
PLoS One. 2007 Feb 14;2(2):e211
pubmed: 17299591
PLoS One. 2011;6(8):e23500
pubmed: 21858144
BMC Microbiol. 2019 Jun 13;19(1):130
pubmed: 31195972
Nat Microbiol. 2019 Dec;4(12):2039-2043
pubmed: 31570866
Gastroenterology. 2013 Aug;145(2):396-406.e1-10
pubmed: 23665276
Open Forum Infect Dis. 2020 Jan 12;7(1):ofaa012
pubmed: 32010736
J Clin Microbiol. 2013 Mar;51(3):894-900
pubmed: 23284030
Cell Host Microbe. 2015 May 13;17(5):662-71
pubmed: 25865369
Am J Public Health Nations Health. 1946 Jul;36(7):739-45
pubmed: 18016380
Infect Immun. 2015 Oct;83(10):3838-46
pubmed: 26169276
N Engl J Med. 2014 Mar 27;370(13):1198-208
pubmed: 24670166
Front Immunol. 2018 Feb 20;9:142
pubmed: 29515566
Appl Microbiol. 1975 Sep;30(3):381-5
pubmed: 810086
Biofouling. 2018 Mar;34(3):287-298
pubmed: 29457734
Curr Microbiol. 2014 Jul;69(1):42-6
pubmed: 24577613
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Front Microbiol. 2019 Feb 11;10:230
pubmed: 30804922
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Sci Rep. 2015 Feb 10;5:8365
pubmed: 25666585
J Clin Microbiol. 2013 Dec;51(12):4073-8
pubmed: 24088853
J Infect Dis. 2019 Jan 29;219(4):637-647
pubmed: 30202982
Mucosal Immunol. 2019 Jan;12(1):1-9
pubmed: 29988120
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
Mol Biosyst. 2012 Oct 30;8(12):3142-65
pubmed: 23044854
J Nutr. 2003 Oct;133(10):3145-8
pubmed: 14519799
Infect Immun. 2001 Sep;69(9):5953-7
pubmed: 11500481
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Nat Protoc. 2010 Apr;5(4):725-38
pubmed: 20360767
Gut. 1978 Sep;19(9):819-22
pubmed: 30683
PLoS Genet. 2019 Apr 15;15(4):e1008114
pubmed: 30986243
Infect Immun. 2020 Oct 19;88(11):
pubmed: 32839189
PeerJ. 2018 Feb 19;6:e4402
pubmed: 29479501
Gut Microbes. 2016 Jul 3;7(4):313-322
pubmed: 27355107
Pathog Glob Health. 2014 Jul;108(5):235-45
pubmed: 25146935
Microbiol Res. 2015 Aug;177:22-7
pubmed: 26211962
Nat Microbiol. 2016 Aug 08;1(10):16131
pubmed: 27670113
Nat Methods. 2015 Jan;12(1):7-8
pubmed: 25549265
Nucleic Acids Res. 2020 Jan 8;48(D1):D606-D612
pubmed: 31667520
BMC Bioinformatics. 2008 Jan 23;9:40
pubmed: 18215316
J Chemother. 2015 Oct;27(5):283-9
pubmed: 24981117
Nucleic Acids Res. 2018 Jan 4;46(D1):D633-D639
pubmed: 29059334
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8499-8504
pubmed: 30975748
J Cancer Prev. 2019 Sep;24(3):173-182
pubmed: 31624723
Microbiology (Reading). 1995 Dec;141 ( Pt 12):3133-40
pubmed: 8574407
Nat Rev Microbiol. 2017 Jul;15(7):384
pubmed: 28579608
J Proteomics. 2016 Mar 16;136:167-73
pubmed: 26778143
Infect Immun. 2004 Jul;72(7):3783-92
pubmed: 15213119
J Bacteriol. 1977 Jan;129(1):276-81
pubmed: 401494
Clin Infect Dis. 2017 Jul 15;65(2):208-215
pubmed: 28369261
mSystems. 2018 Jun 26;3(3):
pubmed: 29963640
J Exp Med. 2019 Jan 7;216(1):84-98
pubmed: 30563917
Clin Microbiol Rev. 1998 Oct;11(4):589-603
pubmed: 9767057
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31061159
Am J Public Health (N Y). 1914 Oct;4(10):917-32
pubmed: 18009117
Nature. 2016 Jun 30;534(7609):697-9
pubmed: 27309805
J Antimicrob Chemother. 2016 Dec;71(12):3416-3419
pubmed: 27559117
Vet Microbiol. 2011 May 12;150(1-2):146-51
pubmed: 21295415
Microbiome. 2016 Jul 07;4(1):36
pubmed: 27388460
J Antimicrob Chemother. 2019 May 1;74(5):1218-1222
pubmed: 30770708
PLoS One. 2019 May 28;14(5):e0217050
pubmed: 31136592
J Bacteriol. 2002 Sep;184(17):4690-8
pubmed: 12169592
Nature. 2016 Jul 06;535(7610):85-93
pubmed: 27383983
Clin Microbiol Rev. 2019 May 15;32(3):
pubmed: 31092506
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):E3574-81
pubmed: 26100894
Genome Res. 2017 May;27(5):722-736
pubmed: 28298431
Infect Immun. 2002 Aug;70(8):4729-34
pubmed: 12117993
Lancet Infect Dis. 2017 Apr;17(4):390-399
pubmed: 28139431
Microbiology (Reading). 2003 Jan;149(Pt 1):167-76
pubmed: 12576590
Infect Immun. 2015 Mar;83(3):934-41
pubmed: 25534943
Cell Host Microbe. 2017 Jun 14;21(6):682-694.e5
pubmed: 28618267
Microbiome. 2018 Nov 13;6(1):204
pubmed: 30424821
Proc Soc Exp Biol Med. 1954 May;86(1):132-7
pubmed: 13177610
Trends Microbiol. 1999 Mar;7(3):111-5
pubmed: 10203839
Microbiology (Reading). 2003 May;149(Pt 5):1285-1295
pubmed: 12724390
J Glob Antimicrob Resist. 2017 Jun;9:130-134
pubmed: 28552831
Mucosal Immunol. 2018 May;11(3):752-762
pubmed: 29411774
PLoS One. 2009 Dec 14;4(12):e8230
pubmed: 20011594
PLoS One. 2015 Nov 04;10(11):e0141984
pubmed: 26536670
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 30988151
Bioinformatics. 2016 Nov 15;32(22):3501-3503
pubmed: 27412096
Nucleic Acids Res. 2014 Jan;42(Database issue):D633-42
pubmed: 24288368
Bioinformatics. 2018 Mar 15;34(6):1037-1039
pubmed: 29106469
Emerg Infect Dis. 2002 Feb;8(2):160-6
pubmed: 11897067
mBio. 2015 Jun 09;6(3):e00775
pubmed: 26060277
Nucleic Acids Res. 2019 Jan 8;47(D1):D666-D677
pubmed: 30289528
J Med Microbiol. 1993 Aug;39(2):155-8
pubmed: 8345511
mBio. 2019 Mar 12;10(2):
pubmed: 30862751
mSphere. 2016 Oct 19;1(5):
pubmed: 27777984
PLoS One. 2015 Feb 12;10(2):e0116704
pubmed: 25675094
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Nat Microbiol. 2020 Feb;5(2):304-313
pubmed: 31907407
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
Nature. 2015 Jan 8;517(7533):205-8
pubmed: 25337874
Cell. 2016 Jun 2;165(6):1332-1345
pubmed: 27259147
Nat Rev Microbiol. 2010 Dec;8(12):843-8
pubmed: 21060316
J Clin Microbiol. 2015 Apr;53(4):1380-2
pubmed: 25631812
Genome Announc. 2017 Oct 19;5(42):
pubmed: 29051233
Cell Metab. 2019 Feb 5;29(2):362-382.e8
pubmed: 30344015
J Vet Med Sci. 2017 Mar 18;79(3):479-485
pubmed: 28123141
Immunol Rev. 2017 Sep;279(1):90-105
pubmed: 28856737
Appl Environ Microbiol. 2009 Feb;75(3):719-28
pubmed: 19047385
J Infect Dis. 2010 Jul 1;202(1):52-64
pubmed: 20497056
Cell Host Microbe. 2016 Apr 13;19(4):443-54
pubmed: 27078066
J Infect Dis. 2019 Apr 8;219(8):1294-1306
pubmed: 30476200
mBio. 2017 May 23;8(3):
pubmed: 28536285
Syst Biol. 2019 Mar 1;68(2):365-369
pubmed: 30165689
J Bacteriol. 1995 Sep;177(17):5016-27
pubmed: 7665479
Microbiome. 2019 Feb 19;7(1):28
pubmed: 30782206
Infect Immun. 2012 Jul;80(7):2464-72
pubmed: 22566508
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
PLoS Comput Biol. 2009 Aug;5(8):e1000465
pubmed: 19680427
Science. 2017 Aug 11;357(6351):570-575
pubmed: 28798125
Front Cell Infect Microbiol. 2017 Oct 12;7:442
pubmed: 29085808
Nat Microbiol. 2019 Jun;4(6):1057-1064
pubmed: 30911125

Auteurs

Jay Vornhagen (J)

Department of Pathology, University of Michigan, Ann Arbor, MI, United States of America.
Department of Microbiology & Immunology, University of Michigan, Ann Arbor, MI, United States of America.

Christine M Bassis (CM)

Department of Internal Medicine/Infectious Diseases Division, University of Michigan, Ann Arbor, MI, United States of America.

Srividya Ramakrishnan (S)

Department of Computer Science, Johns Hopkins University, Baltimore, MD, United States of America.

Robert Hein (R)

Department of Internal Medicine/Infectious Diseases Division, University of Michigan, Ann Arbor, MI, United States of America.

Sophia Mason (S)

Department of Pathology, University of Michigan, Ann Arbor, MI, United States of America.

Yehudit Bergman (Y)

Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.

Nicole Sunshine (N)

Department of Pathology, University of Michigan, Ann Arbor, MI, United States of America.

Yunfan Fan (Y)

Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, United States of America.

Caitlyn L Holmes (CL)

Department of Pathology, University of Michigan, Ann Arbor, MI, United States of America.
Department of Microbiology & Immunology, University of Michigan, Ann Arbor, MI, United States of America.

Winston Timp (W)

Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, United States of America.
Department of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.
Department of Medicine, Division of Infectious Disease, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.

Michael C Schatz (MC)

Department of Computer Science, Johns Hopkins University, Baltimore, MD, United States of America.
Department of Biology, Johns Hopkins University, Baltimore, MD, United States of America.
Simons Center for Quantitative Biology, Cold Spring Harbor, NY, United States of America.

Vincent B Young (VB)

Department of Microbiology & Immunology, University of Michigan, Ann Arbor, MI, United States of America.
Department of Internal Medicine/Infectious Diseases Division, University of Michigan, Ann Arbor, MI, United States of America.

Patricia J Simner (PJ)

Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.

Michael A Bachman (MA)

Department of Pathology, University of Michigan, Ann Arbor, MI, United States of America.
Department of Microbiology & Immunology, University of Michigan, Ann Arbor, MI, United States of America.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH